Stephen I Pelton
Pelton, Stephen I.
VIAF ID: 283437686 (Personal)
Permalink: http://viaf.org/viaf/283437686
Preferred Forms
-
-
- 100 0 _ ‡a Stephen I Pelton
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
futuro das vacinas anti-pneumocócicas conjugadas na prevenção das doenças pneumocócicas em lactentes e crianças | |
The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. | |
Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice | |
HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. | |
HIV related bronchiectasis | |
HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other | |
Immune Response to Pneumococcal Conjugate and Polysaccharide Vaccines in Otitis‐Prone and Otitis‐Free Children | |
Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period | |
The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group | |
Improving the outcome of pneumococcal meningitis | |
Individual Benefit vs Societal Effect of Antibiotic Prescribing for Preschool Children With Recurrent Wheeze. | |
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci | |
Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US. | |
Mortality and readmission in the year following hospitalization for pneumonia among US adults | |
Multinational study of pneumococcal serotypes causing acute otitis media in children. | |
New concepts in otitis media: results of investigations of the Greater Boston Otitis Media Study Group. | |
Nontypeable Streptococcus pneumoniae as an otopathogen | |
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team | |
Otitis media and its consequences: beyond the earache | |
Otitis media: current concepts in diagnosis and management. | |
Otitis Media in the Newborn Infant | |
Panel 8: Vaccines and immunology | |
Parents, physicians, and antibiotic use. | |
Persistence of middle-ear effusion after acute otitis media in children | |
Pharmacokinetics of dapsone in children | |
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors | |
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus | |
Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. | |
Population genomics of post-vaccine changes in pneumococcal epidemiology. | |
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. | |
Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection | |
Prospects for prevention of otitis media | |
Radiographic resolution of lymphocytic interstitial pneumonitis (LIP) in children with human immunodeficiency virus (HIV): not a sign of clinical deterioration. | |
Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. | |
Recent advances in otitis media. 6. Vaccine | |
Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection | |
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis | |
Reported use of antimicrobial agents in children attending a pediatric emergency department. | |
Residency training in community pediatrics | |
Rethinking risk for pneumococcal disease in adults: the role of risk stacking. | |
Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America | |
Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine | |
Role of complement in host defense against pneumococcal otitis media | |
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease | |
Severity of invasive pneumococcal disease in children caused by susceptible and nonsusceptible isolates | |
Sialic acid mediated transcriptional modulation of a highly conserved sialometabolism gene cluster in Haemophilus influenzae and its effect on virulence | |
Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group | |
Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced | |
Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine | |
Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence | |
Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children | |
To Treat or Not to Treat Is the Nagging Question | |
Trends in immunization | |
Trimethoprim/sulfamethoxazole-resistant nontypable Haemophilus influenzae | |
Upper Respiratory Tract Colonization With Streptococcus pneumoniae in Adults | |
Upper respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones. | |
Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease | |
Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM]. | |
Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media | |
Who is at risk of 13-valent conjugated pneumococcal vaccine failure? | |
Xanthomas and hyperlipidemia in a human immunodeficiency virus-infected child receivng highly active antiretroviral therapy |